Finance

Lists
FRNM:NASDAQ
Freenome, Inc.
$16.46
-0.87%
(-0.15) 1D
$16.13
-1.98% (-0.33)
After hours
Closed: Sep 22, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for FRNM...
Open
$16.65
High
$16.86
Low
$16.00
Mkt. cap
1.77B
Avg. vol.
1.04M
Volume
568.00K
52-wk high
$17.48
52-wk low
$9.97
EPS
-$0.07
Shares outstanding
107.45M
No. of employees
378
Open
$16.65
High
$16.86
Low
$16.00
Mkt. cap
1.77B
Avg. vol.
1.04M
Volume
568.00K
52-wk high
$17.48
52-wk low
$9.97
EPS
-$0.07
Shares outstanding
107.45M
No. of employees
378
News stories
From web sources and news partners
About Freenome, Inc.
CEO-
Employees378
Founded2014
HeadquartersBrisbane, California, United States
SectorBiotechnology
Websitefreenome.com
Analyst ratings
Based on 4 analysts giving stock ratings to FRNM in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for FRNM in the last 3 months.
Highest
Current $16.46
$21.00 (+27.62%)
Average
$18.00 (+9.39%)
Lowest
$17.00 (+3.31%)
Analyst
Recommendation
Action
Price target
Projected
Date
Subbu Nambi
Guggenheim
Buy
Initiated
$21.00
+27.6%
08/20/2026
Daniel Brennan
TD Cowen
Buy
Initiated
$17.00
+3.3%
08/18/2026
Mark Massaro
BTIG
Buy
Initiated
$17.00
+3.3%
08/17/2026
Tycho Peterson
Jefferies
Buy
Initiated
$17.00
+3.3%
08/17/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.10M
27.88M
4.22M
2.27M
Cost of goods sold
47.57M
52.08M
440.00K
54.77M
Cost of revenue
47.57M
52.08M
440.00K
54.77M
Research and development expenses
-
-
52.11M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13.72M
13.75M
13.91M
12.71M
Operating expense
13.72M
13.75M
66.03M
12.71M
Total operating expenses
61.29M
65.83M
66.47M
67.48M
Operating income
-60.19M
-37.95M
-62.24M
-65.21M
Other non operating income
-56.00K
78.00K
-1.00K
-1.00K
EBT including unusual items
-58.73M
-38.27M
-63.56M
-69.03M
EBT excluding unusual items
-58.73M
-38.27M
-63.56M
-69.03M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-58.73M
-38.27M
-63.56M
-69.03M
Net profit margin
-5,334.33%
-137.27%
-1,505.42%
-3,035.58%
Earnings per share
-
-
-
-
Interest and investment income
1.51M
2.42M
1.69M
1.04M
Interest expense
-1.00K
-2.82M
-3.00M
-4.86M
Net interest expenses
1.51M
-398.00K
-1.31M
-3.82M
Depreciation and amortization charges
-
-
-
-
EBITDA
-54.18M
-31.73M
-56.06M
-59.09M
Gain or loss from assets sale
-
173.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps